Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|September 22, 2017
Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphomaRichard T Maziarz, Yanni Hao, Annie Guerin, et al.American Health & Drug Benefits|October 1, 2016
Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early ChallengesAlan L Shields, Yanni Hao, Meaghan Krohe, et al.Current Medical Research and Opinion|December 15, 2015
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the USNanxin Li, Yanni Hao, Andrew Kageleiry, et al.Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.Frontiers in Pharmacology|September 19, 2022
Neferine alleviates chronic stress-induced depression by regulating monoamine neurotransmitter secretion and gut microbiota structureZaiquan Dong, Qinglian Xie, Feiyu Xu, et al.Advances in Therapy|May 25, 2016
Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or ChemotherapyYanni Hao, Nanxin Li, Anna P Fang, et al.Journal of Comparative Effectiveness Research|August 15, 2015
Real-world effectiveness of everolimus-based therapy versus fulvestrant monotherapy in HR(+)/HER2(-) metastatic breast cancerYanni Hao, Peggy L Lin, Jipan Xie, et al.Current Medical Research and Opinion|November 4, 2014
Treatment patterns and survival in metastatic breast cancer patients by tumor characteristicsYanni Hao, Nicole Meyer, Xue Song, et al.Journal of Comparative Effectiveness Research|June 22, 2023
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphomaYanni Hao, Wei-Chun Hsu, Craig S Parzynski, et al.Cancer Medicine|December 22, 2015
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician surveyPeggy L Lin, Yanni Hao, Jipan Xie, et al.Pageof 6